BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness

WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner. 

Join MIDI as they provide a practical framework for developing SaMD products with regulatory requirements built into the development process.

Join Genpact as they provide a practical framework for connecting, governing, and activating service data – and a clear roadmap for scaling AI from pilot to confident business outcomes.

Chanhassen, MN — MedSource Labs today announced the launch of the ClearSafe Comfort® Closed System, the first slide-activated safety peripheral IV catheter (PIVC) with an integrated extension set to receive FDA 510(k) clearance.

Join Suntra MedTech as they explore how AI is beginning to reshape the work of Quality and Regulatory—and what must not change.

Join Akin Gump as they provide actionable takeaways to minimize compliance risks and position organizations for effective and credible responses when FCA investigations arise.

WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.